March 4, 2020
Ventas, Inc. completed the initial closing of the previously disclosed Ventas Life Science and Healthcare Real Estate Fund, L.P., a perpetual life vehicle focused on investments in North American core and core-plus life science, medical office and senior housing real estate.
At inception, the fund has more than $0.7 billion in assets under management and third-party equity commitments of approximately $0.65 billion from globally respected institutional investors. To seed the fund, Ventas contributed five stabilized life science and medical office assets totaling 1.2 million square feet.
“This successful launch is a testament to the tremendous market opportunity within life science, medical office and senior housing real estate, and to Ventas’s excellent investment track record,” said Debra Cafaro, chairman and CEO.
The fund will have a conservative capital structure, and has secured a $0.3-billion line of credit to facilitate new investments, Ventas said.
For comments, questions or concerns, please contact Paul Bubny